Haemonetics signs non-exclusive supply deal with CSL Plasma for NexSys PCS devices

HAEMONETICS CORP

Agreement with CSL Plasma Inc. signed Aug 14, 2026 for NexSys PCS devices with Persona PLUS technology and disposables in US.
Non-exclusive; no minimum purchase commitments; CSL to transition portion of US plasma centers but scope/timing undetermined.
Fiscal 2027 guidance unchanged; company to update impact on Q2 FY2027 earnings call in November 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.